U.S. Online Retail and Ecommerce Stock News

Earlier in January, National Storage Affiliates Trust announced a joint venture with an affiliate of Investment Real Estate Management, creating about US$350 million in buying capacity for value-add self-storage properties that will be operated under the Moove In brand. This partnership highlights NSA’s push to expand in markets with favorable population and demand trends while leveraging a regional operator’s local execution capabilities. We’ll now examine how this new US$350 million...

In the past week, Barclays analyst Brendan Lynch downgraded Lineage, Inc. from an “Overweight” to an “Equal-Weight” stance, reflecting a more cautious view of the company’s near-term prospects. This shift comes as several analysts have recently reduced their enthusiasm for Lineage, signaling a broader reassessment of the company’s outlook and risk profile. Next, we’ll examine how this growing analyst caution, particularly Barclays’ downgrade, may influence Lineage’s investment narrative...

OGE Energy (OGE) is reorganizing its commercial operations after OG&E created a new Commercial organization focused on customer engagement, systems planning, and sales, with John Laws appointed as Chief Commercial Officer to lead the effort. See our latest analysis for OGE Energy. At a share price of US$42.97, OGE Energy has recently seen a 1-day share price return of 1.13%, while its 1-year total shareholder return of 9.61% and 5-year total shareholder return of 72.30% suggest momentum has...

In recent days, Airedale by Modine has showcased its broad range of advanced data center cooling technologies, including free‑cooling air‑cooled chillers and intelligent control systems that help operators manage rising thermal densities and improve energy efficiency. A key development is the ability to cool server racks with 45°C water, which broadens the operational window for free and hybrid cooling and offers data centers more flexibility in minimizing Power Usage Effectiveness. Next,...

Option Care Health (OPCH) has drawn fresh attention after its board doubled the share repurchase authorization to $1.0b and paired that with preliminary 2025 results and new 2026 guidance that investors quickly reacted to. See our latest analysis for Option Care Health. The buyback expansion and fresh 2026 guidance have arrived alongside strong recent momentum, with an 8.39% one-day share price return and a 90-day share price return of 28.09%. The 5-year total shareholder return of 83.57%...

American States Water Company recently reported that its water utility subsidiary, Golden State Water Company, received California Public Utilities Commission approval for full second-year rate increases effective January 1, 2026, increasing adopted 2026 water revenue less water supply cost by about US$32.0 million versus 2025. This decision, enabled by Golden State Water meeting earnings tests across all rate-making areas, reinforces the importance of regulatory outcomes in shaping the...

Darling Ingredients (DAR) is back in focus after reporting a robust quarter, with revenue up 10% year on year, beating analyst expectations and topping peers on operating income performance. See our latest analysis for Darling Ingredients. The strong quarter sits alongside a clear pick up in momentum, with a 90 day share price return of 26.55% and a 1 year total shareholder return of 11.38%, even though the 3 and 5 year total shareholder returns of 39.97% and 39.76% declines still weigh on...

Littelfuse (LFUS) is back on investors’ radar after solid recent share performance, with returns of 7% over the past month and 6.4% in the past 3 months, prompting fresh interest. See our latest analysis for Littelfuse. With the share price at $281.2 and a 30 day share price return of 7.22%, Littelfuse’s 1 year total shareholder return of 23.44% suggests momentum has been building rather than fading. If Littelfuse has caught your eye, it may be a good moment to see what else is moving in tech...

Curtiss-Wright and Green Hills Software recently announced a new high-performance COTS platform that pairs Curtiss-Wright’s SOSA-aligned V3-1222 3U VPX module, featuring a 13th Gen Intel Core i7 and Iris Xe graphics, with Green Hills’ FACE-certified INTEGRITY-178 tuMP real-time operating system for safety-certifiable aerospace computing. This alliance extends safety-certifiable multicore computing into demanding defense, commercial aviation, and emerging air mobility uses by combining open...

Mettler-Toledo International Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference and is set to report its fourth-quarter 2025 results after the market close on February 5, 2026, followed by a conference call on February 6. Analysts are highlighting ongoing strength in the Industrial and Laboratory segments, where new product launches, automation, and digitalization are supporting expectations for profit growth despite tariff-related margin pressure. We’ll now examine...

Recent attention on Trane Technologies (TT) follows the successful rollout of an industry first thermal battery storage system in New York City's largest office building, highlighting its approach to sustainable HVAC and carbon reduction. See our latest analysis for Trane Technologies. That thermal battery rollout comes as Trane Technologies’ share price sits at US$391.08, with a 1-day share price return of 1.46% and a 7-day share price return of 2.62%. The 3-year total shareholder return of...

Alphatec Holdings (ATEC) grabbed attention after its 2026 revenue outlook implied slower growth at the same time the company secured exclusive U.S. rights to Theradaptive’s OsteoAdapt bone graft, sending the stock sharply lower. See our latest analysis for Alphatec Holdings. The guidance update and Theradaptive partnership arrived after a volatile stretch for the shares, with a 24.5% 7 day share price return decline and 17.6% 30 day share price return decline, even as the 1 year total...

Why BridgeBio Pharma stock is back in focus BridgeBio Pharma (BBIO) has returned to the spotlight after management outlined fresh clinical and commercial milestones around its ATTR-CM franchise, the FORTIFY Phase 3 program in LGMD2I/R9, and a new TTR amyloid depleter antibody effort. For investors, the combination of growing real-world use of acoramidis, FDA feedback on a potential full approval filing for BBP-418, and the planned TTR antibody program creates a fuller picture of BridgeBio’s...

Halliburton (HAL) is back in focus after promoting Casey Maxwell to president, Western Hemisphere, while his predecessor Mark Richard shifts to a senior advisor role to chairman, president, and CEO Jeff Miller. See our latest analysis for Halliburton. Halliburton’s executive reshuffle comes as the stock’s recent momentum has picked up, with a 30 day share price return of 13.94% and a 90 day share price return of 45.65%. The 1 year total shareholder return sits at 19.07%, while the 3 year...

The Coca-Cola Company recently overhauled its leadership structure, creating a Chief Digital Officer role for Sedef Salingan Sahin and reshaping regional responsibilities across Asia, Africa and the Middle East, while retaining its Costa Coffee business after auction bids fell short of expectations. This combination of a deeper digital push and a renewed commitment to Costa Coffee highlights how Coca-Cola is reshaping its operating model and portfolio mix ahead of upcoming earnings and...

L3Harris Technologies (LHX) has drawn investor attention recently as the stock’s one-month and three-month returns stand at 18.9% and 17.8%, prompting closer scrutiny of its current valuation. See our latest analysis for L3Harris Technologies. That recent 18.9% one month share price return and 17.8% three month share price return come on top of a 12.1% year to date share price return and a 61.8% one year total shareholder return. Together, these figures point to momentum building around...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

KB Home (KBH) recently issued fiscal fourth quarter results that included guidance for revenue below the prior year, sparking a 10% share price drop and cautious commentary on potential gross margin pressure. See our latest analysis for KB Home. Despite the post earnings drop, KB Home’s recent news flow has included new community openings in California and a planned board transition. The 7 day share price return of 9.42% contrasts with a 1 year total shareholder return decline of 5.26%,...

Recently, Rush Enterprises reported quarterly results showing flat year-on-year revenue but a clear beat versus analysts’ expectations, including stronger-than-expected EBITDA, despite ongoing headwinds in the commercial vehicle industry such as soft freight demand, overcapacity, tariffs, and broader economic uncertainty. An interesting angle is that modest growth in higher-margin aftermarket activity and light-duty vehicle sales underpinned this earnings outperformance, highlighting the...

Cushman & Wakefield recently appointed Andy Jansen as President of Project & Development Services for the Americas, effective January 5, 2026, tasking him with leading vision, technology implementation, and sales methodology for the business. Jansen’s background in graph-based technology at NEO4J and his BuiltWorlds co-founding experience introduces a technology-focused approach to Cushman & Wakefield’s project and development services offering. We’ll now examine how Jansen’s...

ACI Worldwide (ACIW) is in focus after announcing it will integrate Early Warning Services’ Paze online checkout into its Pay.On payment orchestration platform, widening digital wallet access for U.S. merchants and consumers. See our latest analysis for ACI Worldwide. The Paze announcement comes after a stretch where momentum has cooled, with a 90 day share price return of 9.68% and a 1 year total shareholder return of 12.92%, set against a stronger 3 year total shareholder return of...

Agios Pharmaceuticals recently outlined its 2026 strategic priorities at the 44th Annual J.P. Morgan Healthcare Conference, emphasizing the ongoing U.S. launch of AQVESME (mitapivat) in thalassemia following its December 2025 FDA approval and upcoming regulatory interactions for mitapivat in sickle cell disease. This update underscores how Agios is working to convert its rare disease pipeline into commercial momentum by expanding mitapivat’s reach across multiple hematologic...

Kahn Swick & Foti, LLC recently reminded ICON investors of an approaching deadline to apply for lead plaintiff status in a securities class action, tied to alleged disclosure failures between July 27, 2023 and October 23, 2024. The reminder revives focus on ICON’s October 2024 revenue shortfall disclosure and could keep legal and regulatory risk firmly in the spotlight for investors. We’ll now examine how this renewed focus on potential disclosure and legal risks may influence ICON’s...

Xenon Pharmaceuticals (XENE) has been drawing attention after recent trading, with the share price at US$40.36 and mixed returns over the past year, including a small one-year gain and a negative year to date. See our latest analysis for Xenon Pharmaceuticals. Recent trading has been softer, with a 1 month share price return showing an 8.4% decline and a year to date share price return showing a 9.3% decline, even though the 5 year total shareholder return of 152.7% points to much stronger...